FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs Arrays Braftovi for Some Cancers

[ Price : $8.95]

FDA approves Array BioPharmas Braftovi to treat some patients with metastatic colorectal cancer with a specific mutation.

FDA OKs Galderma Dermatitis Drug Nemluvio

[ Price : $8.95]

FDA approves Galdermas Nemluvio to treat some dermatitis patients aged 12 and older.

Alcon Recalls Systane Ultra PF Eye Drops

[ Price : $8.95]

FDA says Alcon recalled one lot of Systane Ultra PF eye drops due to potential fungal contamination.

FDA Approves Novo Hemophilia Prophylaxis Drug

[ Price : $8.95]

FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.

New Sleep Apnea Indication for Lillys Zepbound

[ Price : $8.95]

FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.

Astellas Recalls Lots of Prograf and Astagraf

[ Price : $8.95]

FDA says Astellas has recalled one lot each of its Prograf and Astagraf transplant medications that may contain empty capsules.

QS, MDR Violations at Rontis Hellas in Greece

[ Price : $8.95]

FDA warns Greeces Rontis Hellas about Quality System and Medical Device Reporting violations in its production of a balloon cathet...

FDA Approves BMS Opdivo Qvantig Injection

[ Price : $8.95]

FDA approves Bristol Myers Squibbs Opdivo Qvantig subcutaneous injection for several cancer indications.

FDA Approves Checkpoints Unloxcyt

[ Price : $8.95]

FDA approves Checkpoint Therapeutics Unloxcyt to treat some squamous cell cancer patients.

Bhargava Phytolab CGMP Violations

[ Price : $8.95]

FDA warns Indias Bhargava Phytolab about CGMP issues in its manufacturing of finished drugs and active pharmaceutical ingredients....